台湾 生物技術開発中心

The Development Center for Biotechnology (DCB)
With over 400 dedicated researchers and state-of-the-art facilities , the Development Center for Biotechnology (DCB) specializes in developing biologics and small molecule drugs , botanical drugs , as well as technologies required for preclinical testing. Our expertise arises from the integration of a number of diverse disciplines , including biology , chemistry , protein purification and engineering , as well as analytical and quality assurance. Established in 1984 by Taiwan's Ministry of Economic Affairs (MOEA) , Department of Industrial Technology (DoIT) , DCB was initially tasked with establishing the biotechnology industry in Taiwan. Through strategic global alliances and technology transfer agreements , DCB has successfully fostered the development of a complete biotech infrastructure and value chain , as well as a diverse array of applications for use by the private sector. As a result , DCB has become one of Taiwan's most important research institutes.

The Biotechnology and Pharmaceutical Industries Promotion Office (BPIPO)
The Biotechnology and Pharmaceutical Industries Promotion Office (BPIPO) is the single contact window for Taiwan's biomedical industry. It is an one-stop service window designed to assist companies in the biomedical industries worldwide. The assistances provided by BPIPO include: financial support, investment promotion, stock listing, personnel training and recruitment, R&D collaboration, technology transfer, commercialization, marketing, promotion activities, strategic alliances, and others.
Over the past few years, BPIPO has helped Taiwan's biomedical industry to obtain investments of more than US$1,500 million per year. BPIPO has also helped set up more than three innovative companies per year. The One-Stop Service Window has helped more than 100 companies per year.

バイオ医薬産業発展推進オフィス（BPIPO）は、台湾の生物医学産業の唯一の総合窓口です。世界各国の生物医学産業の企業を支援することを目的に設立されました。財政支援、投資促進、株式上場、人材育成および募集、共同研究開発、技術移転、商品化、マーケティング、販売促進活動、戦略的提携などの各方面について支援を行っています。 BPIPOは、年間100社を超える企業を支援しています。ここ数年間で、台湾の生物医学産業が受けた年間15億米ドルを超える投資、1年に3社を超える革新的な企業の設立などは、BPIPOの支援によるものです。